Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes-Reference-Cited by-同舟云学术

Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes

Published:2016-02 Issue:2 Volume:89 Page:459-467
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Nowak Natalia,Skupien Jan,Niewczas Monika A.,Yamanouchi Masayuki,Major Melissa,Croall Stephanie,Smiles Adam,Warram James H.,Bonventre Joseph V.,Krolewski Andrzej S.

Publisher

Elsevier BV

Subject

Nephrology

Reference34 articles.

1. Risk for ESRD in type 1 diabetes remains high despite renoprotection;Rosolowsky;J Am Soc Nephrol,2011

2. FinnDiane Study Group. Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria;Forsblom;J Am Soc Nephrol,2011

3. Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes;Krolewski;Diabetes Care,2015

4. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes;Perkins;J Am Soc Nephrol,2007

5. Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria;Krolewski;Diabetes Care,2014

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex-specific modulation of renal epigenetic and injury markers in aging kidney;American Journal of Physiology-Renal Physiology;2024-09-01

2. Plasma proteomics of acute tubular injury;Nature Communications;2024-08-27

3. The Relationship between Circulating Kidney Injury Molecule-1 and Cardiovascular Morbidity and Mortality in Hemodialysis Patients;Biomedicines;2024-08-20

4. Effect of proteinuria on the rapid kidney function decline in chronic kidney disease depends on the underlying disease: A post hoc analysis of the BRIGHTEN study;Diabetes Research and Clinical Practice;2024-06

5. Determinants of serious health outcome‐free status in middle‐aged and older people with dysglycaemia: Exploratory analysis of the ORIGIN trial;Diabetes, Obesity and Metabolism;2024-05-15